Abnormal Tarsal Bone Mineral Density C4021522
Reduced mineral content in the tarsal bones of the foot, which may indicate bone weakness. It can affect mobility and is often evaluated with imaging. Management focuses on improving bone health.
Key facts at a glance
- ICD-10
- M79.9
- ICD-11
- FA00.0
- Body system
- musculoskeletal
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Foot pain
(musculoskeletal)Joint pain or stiffness
(musculoskeletal)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Difficulty walking
(musculoskeletal)Ankle swelling
(musculoskeletal)Decreased mobility
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Calcium and Vitamin D Supplementation
Adequate intake of calcium and vitamin D supports bone mineralization. Dietary sources include dairy products, leafy greens, and fortified foods, with supplementation considered if dietary intake is insufficient.
Weight-Bearing Exercise Program
Weight-bearing activities such as walking, resistance training, and balance exercises stimulate bone formation and improve skeletal strength in the foot region.
Additional treatment options
Bone Density Monitoring
Regular DEXA scans and clinical assessment track changes in bone mineral density over time, allowing for treatment adjustments as needed.
monitoringFall Prevention Strategies
Environmental modifications, appropriate footwear, and balance training reduce fracture risk in patients with compromised bone density in the foot region.
lifestyleBone-Resorptive Inhibitors
Pharmacological agents that slow bone breakdown may be considered when lifestyle and dietary measures are insufficient to maintain bone health.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Tarsal Bone Mineral Density C4021522?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Abnormal Tarsal Bone Mineral Density C4021522. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy